- Research

A new way to diagnose hereditary cancers is already benefitting patients in the Catalan Health Service thanks to ground-breaking research by the Joint Program on Hereditary Cancer ICO-IDIBELL-IGTP

Researchers of the Joint Program on Hereditary Cancer ICO-IDIBELL-IGTP have designed and tested a new strategy based on next generation sequencing (NGS) for the genetic diagnostics of hereditary cancer. They tested it against other current commercially available NGS methods and the new method gave  better results. Previously patients were only tested for one or a small number of genes but now each patient can be tested for a wide range of genes in one single step and the results analysed using complex computing tools resulting in a much more efficient diagnostic process.  700 patients in the Catalan Health System have already benefitted from the new diagnostic approach

- Campus Can Ruti

EIT Health Spain premia un projecte IGTP

L'associació EIT Health Spain va tancar ahir el seu primer any d'activitat amb un acte al Parc Científic de Barcelona (PCB). La primera part de l'acte ha consistit en diverses presentacions orientades a la preparació de les convocatòries d'Innovació, Campus i Acceleració del proper any.